XML 27 R11.htm IDEA: XBRL DOCUMENT

ACQUISITIONS (Notes)	12 Months Ended
ACQUISITIONS (Notes)	Mar. 28, 2020
Business Combinations [Abstract]
Acquisitions	ACQUISITIONS On April 1, 2020, the Company acquired all of the outstanding equity of enicor GmbH, the manufacturer of ClotPro^®, a new generation whole blood coagulation testing system. The acquisition of this innovative viscoelastic diagnostic device further augments the Company's portfolio of hemostasis analyzers within the Hospital business unit. The purchase accounting for this acquisition will be completed in fiscal 2021. On January 13, 2020, the Company purchased the technology underlying the TEG^® 6s Hemostasis Analyzer System from Cora Healthcare, Inc. and CoraMed Technologies, LLC (the "Cora Parties") for $35.0 million. In connection with this transaction, which did not meet the definition of a business, the Company acquired ownership of intellectual property previously licensed from the Cora Parties on an exclusive basis in the field of hospitals and hospital laboratories. This acquisition will allow the Company to pursue site of care opportunities beyond the hospital setting. The intangible asset acquired as a result of this transaction was recorded in the Company's Hospital business unit.